TAG: ceu - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
According to the term you entered "ceu": 24 news found
main-post-image
HEALTH
Approval of First Malaria Treatment for Infants Marks a Critical Public Health Milestone

Novartis' new malaria treatment for infants, Coartem Baby, has received approval, aiming to reduce malaria's devastating impact on young children.

Read more
main-post-image
WORLD NEWS
Death toll rises to 36 in Sigachi Industries fire and explosion in Telangana

At least 36 confirmed dead after a massive explosion at Sigachi Industries' pharmaceutical factory in Telangana, India.

Read more
main-post-image
ECONOMY
Trump's Executive Order Aims to Cut Prescription Drug Prices by Up to 80%

Trump's new executive order seeks to drastically lower prescription drug prices in the U.S., aligning them with prices in other countries.

Read more
main-post-image
ECONOMY
Trump Administration Moves Forward with Investigations for New Tariffs on Semiconductors and Pharmaceuticals

Trump administration launches investigations potentially leading to new tariffs on semiconductors and pharmaceuticals to bolster U.S. manufacturing.

Read more
main-post-image
ECONOMY
Trump Introduces Major Tariffs on Pharmaceuticals: Implications for Drug Prices and Manufacturing

Donald Trump announces impending major tariffs on pharmaceutical imports, raising concerns about soaring drug prices and potential shortages.

Read more
main-post-image
TECHNOLOGY
Walgreens to be Acquired by Sycamore Partners in $10 Billion Deal

Walgreens to be taken private by Sycamore Partners in a nearly $10 billion deal amid financial struggles and ongoing store closures.

Read more
main-post-image
ENTERTAINMENT
Jon Stewart's Fiery Rant on 'The Daily Show' Leads to Accidental Injury

Jon Stewart suffers a cut hand during a heated segment criticizing government inefficiencies and pharmaceutical prices on 'The Daily Show'.

Read more
main-post-image
ECONOMY
FDA Approves Journavx: A Non-Opioid Painkiller Aimed at Reducing Addiction Risks

The FDA has approved Journavx, a new non-opioid pain medication, aiming to combat opioid addiction and overdose risks in patients.

Read more
main-post-image
ECONOMY
Li Ka-shing's Hutchmed to Sell $608 Million Stake in Health Unit

Hutchmed, controlled by billionaire Li Ka-shing, is set to sell a $608 million stake in its health unit to enhance capital and focus on core operations.

Read more
main-post-image
ECONOMY
Trump's Tariffs Impacting Pharmaceutical Industry

Trump's tariffs pose significant challenges for the pharmaceutical industry, impacting costs and accessibility.

Read more
123